BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9450472)

  • 1. Uterine carcinoma in mice treated neonatally with tamoxifen.
    Newbold RR; Jefferson WN; Padilla-Burgos E; Bullock BC
    Carcinogenesis; 1997 Dec; 18(12):2293-8. PubMed ID: 9450472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of uterine tumours in CD-1 mice treated neonatally with subcutaneous tamoxifen or 4-hydroxyoestradiol.
    Razvi N; Greaves P; Styles J; Edwards R; White IN
    Exp Toxicol Pathol; 2007 Nov; 59(3-4):177-85. PubMed ID: 17825543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis.
    Newbold RR; Bullock BC; McLachlan JA
    Cancer Res; 1990 Dec; 50(23):7677-81. PubMed ID: 2174729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen.
    Diwan BA; Anderson LM; Ward JM
    Carcinogenesis; 1997 Oct; 18(10):2009-14. PubMed ID: 9364013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol.
    Sato T; Ohta Y; Okamura H; Hayashi S; Iguchi T
    Anat Rec; 1996 Mar; 244(3):374-85. PubMed ID: 8742702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental administration of diethylstilbestrol (DES) causes lesions in female reproductive organs of Donryu rats, including endometrial neoplasia.
    Kitamura T; Nishimura S; Sasahara K; Yoshida M; Ando J; Takahashi M; Shirai T; Maekawa A
    Cancer Lett; 1999 Jul; 141(1-2):219-28. PubMed ID: 10454265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine adenocarcinoma in mice treated neonatally with genistein.
    Newbold RR; Banks EP; Bullock B; Jefferson WN
    Cancer Res; 2001 Jun; 61(11):4325-8. PubMed ID: 11389053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract.
    Newbold RR; Jefferson WN; Padilla-Banks E
    Reprod Toxicol; 2007; 24(2):253-8. PubMed ID: 17804194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological changes in female C3H mice continuously fed diets containing diethylstilbestrol or 17beta--estradiol.
    Highman B; Norvell MJ; Shellenberger TE
    J Environ Pathol Toxicol; 1978; 1(1):1-30. PubMed ID: 722180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive tract abnormalities in female mice treated neonatally with tamoxifen.
    Taguchi O; Nishizuka Y
    Am J Obstet Gynecol; 1985 Mar; 151(5):675-8. PubMed ID: 3976766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive abnormalities in female mice exposed neonatally to various doses of coumestrol.
    Burroughs CD; Mills KT; Bern HA
    J Toxicol Environ Health; 1990 Jun; 30(2):105-22. PubMed ID: 2355401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia.
    Carthew P; Edwards RE; Nolan BM; Martin EA; Heydon RT; White IN; Tucker MJ
    Carcinogenesis; 2000 Apr; 21(4):793-7. PubMed ID: 10753217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G; Dauplat J
    Rev Fr Gynecol Obstet; 1992 Jun; 87(6):345-8. PubMed ID: 1631476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract.
    Cunha GR; Taguchi O; Namikawa R; Nishizuka Y; Robboy SJ
    Hum Pathol; 1987 Nov; 18(11):1132-43. PubMed ID: 3679188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol.
    Couse JF; Davis VL; Hanson RB; Jefferson WN; McLachlan JA; Bullock BC; Newbold RR; Korach KS
    Mol Carcinog; 1997 Aug; 19(4):236-42. PubMed ID: 9290700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens.
    Newbold RR; Liehr JG
    Cancer Res; 2000 Jan; 60(2):235-7. PubMed ID: 10667565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.